72 related articles for article (PubMed ID: 38475702)
21. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021.
Ehde DM; Roberts MK; Humbert AT; Herring TE; Alschuler KN
Mult Scler Relat Disord; 2021 Sep; 54():103163. PubMed ID: 34325399
[TBL] [Abstract][Full Text] [Related]
22. Impact of prior COVID-19 infection on perceptions about the benefit and safety of COVID-19 vaccines.
Thorpe A; Gurmankin Levy A; Scherer LD; Scherer AM; Drews FA; Butler JM; Fagerlin A
Am J Infect Control; 2024 Jan; 52(1):125-128. PubMed ID: 37544513
[TBL] [Abstract][Full Text] [Related]
23. Demographic, structural, and psychological predictors of risk-increasing and mask wearing behaviors among US adults between December 2020-March 2021.
Thorpe A; Zhong L; Scherer LD; Drews FA; Shoemaker H; Fagerlin A
Patient Educ Couns; 2023 Sep; 114():107792. PubMed ID: 37201301
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with COVID-19 vaccination during June-October 2021: A multi-site prospective study.
Datar RS; Fette LM; Hinkelman AN; Hammershaimb EA; Friedman-Klabanoff DJ; Mongraw-Chaffin M; Weintraub WS; Ahmed N; Gibbs MA; Runyon MS; Plumb ID; Thompson W; Saydah S; Edelstein SL; Berry AA;
Vaccine; 2023 May; 41(20):3204-3214. PubMed ID: 37069033
[TBL] [Abstract][Full Text] [Related]
25. Misrepresentation and Nonadherence Regarding COVID-19 Public Health Measures.
Levy AG; Thorpe A; Scherer LD; Scherer AM; Drews FA; Butler JM; Burpo N; Shoemaker H; Stevens V; Fagerlin A
JAMA Netw Open; 2022 Oct; 5(10):e2235837. PubMed ID: 36215070
[TBL] [Abstract][Full Text] [Related]
26. Communicating about COVID-19 vaccine development and safety.
Thorpe A; Fagerlin A; Butler J; Stevens V; Drews FA; Shoemaker H; Riddoch MS; Scherer LD
PLoS One; 2022; 17(8):e0272426. PubMed ID: 35930557
[TBL] [Abstract][Full Text] [Related]
27. A longitudinal study of vaccine hesitancy attitudes and social influence as predictors of COVID-19 vaccine uptake in the US.
Latkin C; Dayton L; Miller J; Yi G; Balaban A; Boodram B; Uzzi M; Falade-Nwulia O
Hum Vaccin Immunother; 2022 Nov; 18(5):2043102. PubMed ID: 35417302
[TBL] [Abstract][Full Text] [Related]
28. Communications to Promote Interest and Confidence in COVID-19 Vaccines.
Thorpe A; Fagerlin A; Drews FA; Butler J; Stevens V; Riddoch MS; Scherer LD
Am J Health Promot; 2022 Jul; 36(6):976-986. PubMed ID: 35411819
[TBL] [Abstract][Full Text] [Related]
29. Determinants and Trends of COVID-19 Vaccine Hesitancy and Vaccine Uptake in a National Cohort of US Adults: A Longitudinal Study.
Rane MS; Kochhar S; Poehlein E; You W; Robertson MM; Zimba R; Westmoreland DA; Romo ML; Kulkarni SG; Chang M; Berry A; Parcesepe AM; Maroko AR; Grov C; Nash D;
Am J Epidemiol; 2022 Mar; 191(4):570-583. PubMed ID: 34999751
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.
Diesel J; Sterrett N; Dasgupta S; Kriss JL; Barry V; Vanden Esschert K; Whiteman A; Cadwell BL; Weller D; Qualters JR; Harris L; Bhatt A; Williams C; Fox LM; Meaney Delman D; Black CL; Barbour KE
MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(25):922-927. PubMed ID: 34166331
[TBL] [Abstract][Full Text] [Related]
31. Public acceptance of COVID-19 vaccines: cross-national evidence on levels and individual-level predictors using observational data.
Lindholt MF; Jørgensen F; Bor A; Petersen MB
BMJ Open; 2021 Jun; 11(6):e048172. PubMed ID: 34130963
[TBL] [Abstract][Full Text] [Related]
32. Factors Associated With Racial/Ethnic Group-Based Medical Mistrust and Perspectives on COVID-19 Vaccine Trial Participation and Vaccine Uptake in the US.
Thompson HS; Manning M; Mitchell J; Kim S; Harper FWK; Cresswell S; Johns K; Pal S; Dowe B; Tariq M; Sayed N; Saigh LM; Rutledge L; Lipscomb C; Lilly JY; Gustine H; Sanders A; Landry M; Marks B
JAMA Netw Open; 2021 May; 4(5):e2111629. PubMed ID: 34042990
[TBL] [Abstract][Full Text] [Related]
33. Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial.
Freeman D; Loe BS; Yu LM; Freeman J; Chadwick A; Vaccari C; Shanyinde M; Harris V; Waite F; Rosebrock L; Petit A; Vanderslott S; Lewandowsky S; Larkin M; Innocenti S; Pollard AJ; McShane H; Lambe S
Lancet Public Health; 2021 Jun; 6(6):e416-e427. PubMed ID: 33991482
[TBL] [Abstract][Full Text] [Related]
34. Demographic and Social Factors Associated with COVID-19 Vaccination Initiation Among Adults Aged ≥65 Years - United States, December 14, 2020-April 10, 2021.
Whiteman A; Wang A; McCain K; Gunnels B; Toblin R; Lee JT; Bridges C; Reynolds L; Murthy BP; Qualters J; Singleton JA; Fox K; Stokley S; Harris L; Gibbs-Scharf L; Abad N; Brookmeyer KA; Farrall S; Pingali C; Patel A; Link-Gelles R; Dasgupta S; Gharpure R; Ritchey MD; Barbour KE
MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):725-730. PubMed ID: 33983911
[TBL] [Abstract][Full Text] [Related]
35. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications.
Paul E; Steptoe A; Fancourt D
Lancet Reg Health Eur; 2021 Feb; 1():100012. PubMed ID: 33954296
[TBL] [Abstract][Full Text] [Related]
36. Individual and social determinants of COVID-19 vaccine uptake.
Viswanath K; Bekalu M; Dhawan D; Pinnamaneni R; Lang J; McLoud R
BMC Public Health; 2021 Apr; 21(1):818. PubMed ID: 33910558
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 and vaccine hesitancy: A longitudinal study.
Fridman A; Gershon R; Gneezy A
PLoS One; 2021; 16(4):e0250123. PubMed ID: 33861765
[TBL] [Abstract][Full Text] [Related]
38. Predictors of willingness to get a COVID-19 vaccine in the U.S.
Kelly BJ; Southwell BG; McCormack LA; Bann CM; MacDonald PDM; Frasier AM; Bevc CA; Brewer NT; Squiers LB
BMC Infect Dis; 2021 Apr; 21(1):338. PubMed ID: 33845781
[TBL] [Abstract][Full Text] [Related]
39. Coronavirus conspiracy suspicions, general vaccine attitudes, trust and coronavirus information source as predictors of vaccine hesitancy among UK residents during the COVID-19 pandemic.
Allington D; McAndrew S; Moxham-Hall V; Duffy B
Psychol Med; 2023 Jan; 53(1):236-247. PubMed ID: 33843509
[TBL] [Abstract][Full Text] [Related]
40. Communicating Scientific Uncertainty About the COVID-19 Pandemic: Online Experimental Study of an Uncertainty-Normalizing Strategy.
Han PKJ; Scharnetzki E; Scherer AM; Thorpe A; Lary C; Waterston LB; Fagerlin A; Dieckmann NF
J Med Internet Res; 2021 Apr; 23(4):e27832. PubMed ID: 33769947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
